Author: OurCrowd

[OurCrowd in Globes] OurCrowd opens Singapore office

[OurCrowd in Globes] OurCrowd opens Singapore office

Nov 28, 2016 | ,

The Israeli equity crowdfunding company’s seventh office will serve its growing community of Asian investors. Israeli equity crowdfunding company OurCrowd announced today that it has opened an office in Singapore, its seventh office worldwide. The new office will serve the growing community of Asian investors interested in funding early stage high-growth companies. Jerusalem based OurCrowd has appointed Denes Ban, a successful entrepreneur and technology executive, as Managing Partner Asia and head of OurCrowd’s Singapore Management company. Read more on Globes...

Read More

[Zebra in Business Wire] Zebra Medical Vision and Clalit health services announce algorithm that can increase osteoporosis detection by 50%

Nov 28, 2016 |

Zebra Medical Vision (https://www.zebra-med.com) and Clalit Health Services are announcing the completion of a software algorithm which uses existing CT data to identify candidates for bone density screening, allowing earlier identification of patients at higher risk of Osteoporotic fractures. The osteoporosis algorithm was developed in collaboration with the Clalit Research Institute and has received wide interest from various healthcare providers around the world. Read more on Business Wire...

Read More
What is bringing Startup Nation to the developing world? [OurCrowd Newsletter]

What is bringing Startup Nation to the developing world? [OurCrowd Newsletter]

Nov 28, 2016 |

What can be done to bring Israel’s technology and innovation to the developing world?  Read up on this news item and more from the Startup Nation, below… Start getting this weekly newsletter via email: Subscribe now Here’s one way to bring Startup Nation to the developing world Israel is one of the world’s innovation giants. However, at present, most Israeli technologies benefit just 15% of the world’s population in the developed world. Read more. OurCrowd & Portfolio Companies in the News Zebra featured in VentureBeat Freightos featured in CNBC BioCatch featured in Enterprise Times   Israel signs R&D cooperation deal with Chile Agreement will connect startups, technology and research on desert irrigation and development of solar energy. Read more. Geektime’s first Devfest kicks off in Tel Aviv for Techfest 2016 Developers from across Israel and the world gathered in Tel Aviv for the country’s first ever Devfest. Read more. US-Israeli foundation to invest $12M in first responder tech All in all, the total $12M, which will include private sector funding, will be distributed over three years. Read more. Israel fund to raise $50M to...

Read More

[Syqe in Reuters] Teva Pharm to market medical cannabis inhaler in Israel

Nov 28, 2016 | ,

Israel’s Teva Pharmaceuticals has partnered with Tel Aviv-based Syqe Medical to market in Israel medical cannabis for pain management that is administered with an inhaler. The companies said in a statement on Monday that this is the first time the medical cannabis sector has complied with pharmaceutical standards for inhalation, which is the most efficient means for administering the plant. Read more on Reuters...

Read More

[Zebra in The Times of Israel] Israel’s Zebra helps users get second opinion on scans

Nov 27, 2016 |

CT scans don’t always provide all the answers patients are looking for, but getting a second medical opinion costs time and money. Now Israeli startup Zebra Medical Vision has machine learning platform that can provide those second opinions. Zebra’s online software, called Profound, reads data from CT scans, analyzes the information and produces medical reports with 90 percent accuracy, the company said. “Usually when you go to the hospital for a visit, for example, if you have a chest pain, you go for that particular symptom. The doctor looks for that specific sign looking for the cause, but there is always something that he can’t find, and often he doesn’t have the time to look at the entire scenario,” said Zebra’s CEO Elad Benjamin. Read more on The Times of Israel...

Read More